Ask a revenue cycle team how they manage denials and most will describe an appeals process. Ask them which denial reasons drove last month’s volume and the room goes quiet. That gap is the whole problem. Appeals are the expensive end of the cycle; prevention is the cheap end, and nobody is working it because nobody can see it.
Across the organizations we have diagnosed, four reason codes typically account for roughly seventy percent of denied dollars: authorization absent or invalid (CO-197), information missing or invalid (CO-16), non-covered or not medically necessary (CO-50), and timely filing (CO-29). None of these are clinical disputes. All of them are process failures with a known owner.
Days 1 to 30: measure one way
Pull twelve months of 835 remittances and categorize every denial by CARC and RARC, then by the department that could have prevented it. Do not use the practice management system’s built-in denial reports; they usually aggregate by financial class and hide the cause. You want a table with reason code, payer, department, count, and dollars, sorted by dollars.
Agree on one definition of denial rate (denied claims divided by claims submitted, first pass, by dollars) and publish it. Most organizations discover their reported rate was undercounting by a third.
Days 30 to 60: move the fix upstream
For CO-197, the fix is an authorization worklist that runs 72 hours before the visit, not an appeals queue afterwards. For CO-16, it is scrubber rules built from your own denial history, per payer. For CO-29, it is a daily report of claims within ten days of the filing limit, worked before anything else. Each of these is an automation candidate, and each removes work rather than adding it.
Days 60 to 90: appeal what is left, with leverage
The appeals that remain should be high-dollar and winnable. Draft them from a template per reason code, cite the payer’s own policy, and attach the evidence the first time. Track overturn rate by payer and reason, and escalate the payers whose overturn rate exceeds sixty percent: a payer that reverses most of its own denials is denying to manage cash flow, and that is a contract conversation, not a billing one.
By day ninety you should see first-pass denials down by a third and appeals volume down by half. The team is not working harder. It is working the right end of the cycle.